
Cullinan Therapeutics Inc (CGEM) recently have taken one step ahead with the beta value of -0.04
Cullinan Therapeutics Inc (NASDAQ: CGEM) established initial surge of 10.71% at $8.68, as the Stock market unbolted on Thursday, before settling in for the price